Trial NCT00437489

View at ClinicalTrials.gov 
Org. Study IDs: A2171086

Last trial update was posted on 2009-05-11

MeSH Interventions

Insulin Insulin, Globin Zinc

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

This protocol was terminated not for safety reasons, but because Pfizer decided to return the worldwide rights for Exubera to Nektar, on 18 October 2007.

Limitations And Caveats

As a result of Pfizer's decision (18Oct2007) to return the worldwide rights for Exubera (insulin human [rDNA origin]) Inhalation Powder) to Nektar, from which Pfizer licensed inhaled insulin technology, it was decided to terminate this study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID